| [1] |
HUANG Z T, LUO Y, HAN L, et al. Patterns of cardiometabolic multimorbidity and the risk of depressive symptoms in a longitudinal cohort of middle-aged and older Chinese[J]. J Affect Disord, 2022, 301: 1-7. DOI: 10.1016/j.jad.2022.01.030.
|
| [2] |
ZHAO X H, XU X L, YAN Y F, et al. Independent and joint associations of cardiometabolic multimorbidity and depression on cognitive function: findings from multi-regional cohorts and generalisation from community to clinic[J]. Lancet Reg Health West Pac, 2024, 51: 101198. DOI: 10.1016/j.lanwpc.2024.101198.
|
| [3] |
Emerging Risk Factors Collaboration, DI ANGELANTONIO E, KAPTOGE S, et al. Association of cardiometabolic multimorbidity with mortality[J]. JAMA, 2015, 314(1): 52-60. DOI: 10.1001/jama.2015.7008.
|
| [4] |
KIVIMÄKI M, STRANDBERG T, PENTTI J, et al. Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study[J]. Lancet Diabetes Endocrinol, 2022, 10(4): 253-263. DOI: 10.1016/S2213-8587(22)00033-X.
|
| [5] |
KIVIMÄKI M, KUOSMA E, FERRIE J E, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe[J]. Lancet Public Health, 2017, 2(6): e277-e285. DOI: 10.1016/S2468-2667(17)30074-9.
|
| [6] |
WOOLCOTT O O, BERGMAN R N. Relative fat mass(RFM) as a new estimator of whole-body fat percentage—a cross-sectional study in American adult individuals[J]. Sci Rep, 2018, 8(1): 10980. DOI: 10.1038/s41598-018-29362-1.
|
| [7] |
FAN Y J, FENG Y J, MENG Y, et al. The relationship between anthropometric indicators and health-related quality of life in a community-based adult population: a cross-sectional study in Southern China[J]. Front Public Health, 2022, 10: 955615. DOI: 10.3389/fpubh.2022.955615.
|
| [8] |
CAO C C, HUANG M L, HAN Y, et al. The nonlinear connection between relative fat mass and non-alcoholic fatty liver disease in the Japanese population: an analysis based on data from a cross-sectional study[J]. Diabetol Metab Syndr, 2024, 16(1): 236. DOI: 10.1186/s13098-024-01472-z.
|
| [9] |
YU P, HUANG T, HU S L, et al. Predictive value of relative fat mass algorithm for incident hypertension: a 6-year prospective study in Chinese population[J]. BMJ Open, 2020, 10(10): e038420. DOI: 10.1136/bmjopen-2020-038420.
|
| [10] |
ZWARTKRUIS V W, SUTHAHAR N, IDEMA D L, et al. Relative fat mass and prediction of incident atrial fibrillation, heart failure and coronary artery disease in the general population[J]. Int J Obes(Lond), 2023, 47(12): 1256-1262. DOI: 10.1038/s41366-023-01380-8.
|
| [11] |
WANG D, CHEN Z T, WU Y R, et al. Association between two novel anthropometric measures and type 2 diabetes in a Chinese population[J]. Diabetes Obes Metab, 2024, 26(8): 3238-3247. DOI: 10.1111/dom.15651.
|
| [12] |
HU X M, LIU Q Z, GUO X Y, et al. The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus[J]. Cardiovasc Diabetol, 2022, 21(1): 117. DOI: 10.1186/s12933-022-01554-0.
|
| [13] |
|
| [14] |
|
| [15] |
ZHANG D D, TANG X, SHEN P, et al. Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study[J]. BMJ Open, 2019, 9(3): e024476. DOI: 10.1136/bmjopen-2018-024476.
|
| [16] |
HU Y D, WANG Z X, HE H J, et al. Prevalence and patterns of multimorbidity in China during 2002-2022: a systematic review and meta-analysis[J]. Ageing Res Rev, 2024, 93: 102165. DOI: 10.1016/j.arr.2023.102165.
|
| [17] |
TANG R Y, FAN Y B, LUO M, et al. General and central obesity are associated with increased severity of the VMS and sexual symptoms of menopause among Chinese women: a longitudinal study[J]. Front Endocrinol(Lausanne), 2022, 13: 814872. DOI: 10.3389/fendo.2022.814872.
|
| [18] |
JUPPI H K, SIPILÄ S, FACHADA V, et al. Total and regional body adiposity increases during menopause-evidence from a follow-up study[J]. Aging Cell, 2022, 21(6): e13621. DOI: 10.1111/acel.13621.
|
| [19] |
PALMER B F, CLEGG D J. The sexual dimorphism of obesity[J]. Mol Cell Endocrinol, 2015, 402: 113-119. DOI: 10.1016/j.mce.2014.11.029.
|
| [20] |
KAHN D, MACIAS E, ZARINI S, et al. Exploring visceral and subcutaneous adipose tissue secretomes in human obesity: implications for metabolic disease[J]. Endocrinology, 2022, 163(11): bqac140. DOI: 10.1210/endocr/bqac140.
|
| [21] |
AHMED B, SULTANA R, GREENE M W. Adipose tissue and insulin resistance in obese[J]. Biomed Pharmacother, 2021, 137: 111315. DOI: 10.1016/j.biopha.2021.111315.
|
| [22] |
YU F Z, ZONG B Y, JI L L, et al. Free fatty acids and free fatty acid receptors: role in regulating arterial function[J]. Int J Mol Sci, 2024, 25(14): 7853. DOI: 10.3390/ijms25147853.
|
| [23] |
FAULKNER J L, BELIN DE CHANTEMÈLE E J. Sex hormones, aging and cardiometabolic syndrome[J]. Biol Sex Differ, 2019, 10(1): 30. DOI: 10.1186/s13293-019-0246-6.
|
| [24] |
SCHIFFER L, KEMPEGOWDA P, ARLT W, et al. MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease[J]. Eur J Endocrinol, 2017, 177(3): R125-R143. DOI: 10.1530/EJE-17-0124.
|
| [25] |
SANTOS-MARCOS J A, MORA-ORTIZ M, TENA-SEMPERE M, et al. Interaction between gut microbiota and sex hormones and their relation to sexual dimorphism in metabolic diseases[J]. Biol Sex Differ, 2023, 14(1): 4. DOI: 10.1186/s13293-023-00490-2.
|
| [26] |
KVANDOVA M, PUZSEROVA A, BALIS P. Sexual dimorphism in cardiometabolic diseases: the role of AMPK[J]. Int J Mol Sci, 2023, 24(15): 11986. DOI: 10.3390/ijms241511986.
|
| [27] |
WANG J, GUAN J Y, HUANG L Y, et al. Sex differences in the associations between relative fat mass and all-cause and cardiovascular mortality: a population-based prospective cohort study[J]. Nutr Metab Cardiovasc Dis, 2024, 34(3): 738-754. DOI: 10.1016/j.numecd.2023.10.034.
|
| [28] |
JUNGO K T, CHEVAL B, SIEBER S, et al. Life-course socioeconomic conditions, multimorbidity and polypharmacy in older adults: a retrospective cohort study[J]. PLoS One, 2022, 17(8): e0271298. DOI: 10.1371/journal.pone.0271298.
|
| [29] |
HERMAN R, KRAVOS N A, JENSTERLE M, et al. Metformin and insulin resistance: a review of the underlying mechanisms behind changes in GLUT4-mediated glucose transport[J]. Int J Mol Sci, 2022, 23(3): 1264. DOI: 10.3390/ijms23031264.
|
| [30] |
SHI Y J, YANG C G, QIAO W B, et al. Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction[J]. Eur J Pharmacol, 2023, 961: 176170. DOI: 10.1016/j.ejphar.2023.176170.
|
| [31] |
WANG J J, HE W, CAI X F, et al. Relative fat mass and risk of metabolic dysfunction associated steatotic liver disease and severe hepatic steatosis in U.S. adults: analysis of NHANES 2017-2020 data[J]. BMC Gastroenterol, 2025, 25(1): 410. DOI: 10.1186/s12876-025-04006-7.
|
| [32] |
STRACK C, BEHRENS G, SAG S, et al. Gender differences in cardiometabolic health and disease in a cross-sectional observational obesity study[J]. Biol Sex Differ, 2022, 13(1): 8. DOI: 10.1186/s13293-022-00416-4.
|
| [33] |
FAN J N, SUN Z J, YU C Q, et al. Multimorbidity patterns and association with mortality in 0.5 million Chinese adults[J]. Chin Med J(Engl), 2022, 135(6): 648-657. DOI: 10.1097/CM9.0000000000001985.
|
| [34] |
CHUDASAMA Y V, KHUNTI K, GILLIES C L, et al. Healthy lifestyle and life expectancy in people with multimorbidity in the UK Biobank: a longitudinal cohort study[J]. PLoS Med, 2020, 17(9): e1003332. DOI: 10.1371/journal.pmed.1003332.
|
| [35] |
DI CHIARA T, SCAGLIONE A, CORRAO S, et al. Association between low education and higher global cardiovascular risk[J]. J Clin Hypertens(Greenwich), 2015, 17(5): 332-337.
|
| [36] |
WOOLCOTT O O, BERGMAN R N. Defining cutoffs to diagnose obesity using the relative fat mass(RFM): association with mortality in NHANES 1999-2014[J]. Int J Obes(Lond), 2020, 44(6): 1301-1310.
|